跳至主要内容
临床试验/CTRI/2025/03/082114
CTRI/2025/03/082114尚未招募3 期

Efficacy of Platelet Rich Plasma and 308nm Excimer laser versus 308nm Excimer laser alone in stable vitiligo patients

GSL Medical College1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2025年3月21日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
This study is expected to reveal the efficacy of combining Platelet Rich Plasma with 308-nm Excimer laser therapy compared to 308-nm Excimer laser therapy alone in Stable Vitiligo lesions.

研究概览

简要总结

Vitiligo is characterized by depigmented macules causing cosmetic disability, which results in great psychosocial stress. Many treatment methods are available for vitiligo. Many a time, medical therapy alone is not satisfactory.

308-nm excimer laser has proved to be effective in the treatment of limited vitiligo. Platelet-rich plasma (PRP) is an autologous blood product having a large concentration of platelets which  contains variety of growth factors which may stimulate melanocyte proliferation and re-pigmentation in the vitiligo lesions. Though there are studies about Excimer Laser or Platelet rich Plasma in vitiligo individually, there are no studies regarding combination of 308-nm excimer laser with platelet rich plasma in the treatment of stable vitiligo lesions from India. Hence, this study will add value to the literature.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 18-60 years.
  • Vitiligo patients with stable lesions for at least one year.
  • Patients who are willing to give consent.

排除标准

  • Patients with unstable vitiligo.
  • Patients who are not willing to give consent.
  • Infections.
  • Patients with bleeding disorders.
  • Patients on anticoagulants.
  • Patients with history of skin cancer, keloid, hypertrophic scar, psoriasis, lichen planus, photosensitivity disorders and Koebner’s phenomenon.

结局指标

主要结局

This study is expected to reveal the efficacy of combining Platelet Rich Plasma with 308-nm Excimer laser therapy compared to 308-nm Excimer laser therapy alone in Stable Vitiligo lesions.

时间窗: Baseline and after 4 months

次要结局

  • Side effects will be noted for both Platelet Rich Plasma & Excimer Laser treatments during each visit(Baseline & weekly twice for 4 months)

研究者

发起方
GSL Medical College
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

KARNATI LAKSHMI VENKATA VIKRAMNATH REDDY

GSL MEDICAL COLLEGE AND GENERAL HOSPITAL

研究点 (1)

Loading locations...

相似试验